The Fusion Pharmaceuticals brand, founded in 2014 (Canada), from 585 sister brands and 17478 competing brands. The Fusion Pharmaceuticals brand is owned by ASTRAZENECA, a company listed in London. Its International Securities Identification Number (ISIN) is GB0009895292. The sector of Fusion Pharmaceuticals is Drug Manufacturers.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(Fusion Pharmaceuticals)
over 5 years*
GBX 25,905.55